Tender Offer - ELI LILLY & Co

Form Type: SC TO-C

Filing Date: 2025-06-17

Corporate Action: Tender-offer

Type: New

Accession Number: 000119312525142044

Filing Summary: Eli Lilly & Company, through its indirect wholly-owned subsidiary Ridgeway Acquisition Corporation, is preparing to launch a tender offer for all outstanding shares of common stock of Verve Therapeutics, Inc. This announcement follows the execution of a Merger Agreement dated June 16, 2025. The tender offer has not yet commenced, and this filing serves informational purposes only, with no solicitation to purchase or sell securities included. Following the commencement of the tender offer, detailed materials will be made available to investors and stockholders, including an Offer to Purchase and a Solicitation/Recommendation Statement that will summarize the proposed acquisition and other relevant information. The document also includes forward-looking statements related to the potential acquisition and associated risks. Investors are encouraged to review future filings when available to make informed decisions regarding the tendering of shares.